Scale-up and optimization of an evaporative drying process applied to aqueous dispersions of solid lipid nanoparticles

被引:9
作者
Marengo, E
Cavalli, R
Rovero, G
Gasco, MR
机构
[1] Univ Turin, Dipartimento Sci & Tecnol Farmaco, I-10125 Turin, Italy
[2] Univ Piemonte Orientale, Dipartimento Sci & Tecnol Avanzate, Novara, Italy
[3] Politecn Torino, Dipartimento Sci Mat & Ingn Chim, Turin, Italy
关键词
solid lipid nanoparticle dispersion; evaporative drying; scale-up; evaporative-drying intensification;
D O I
10.1081/PDT-120022158
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
An apparatus to dry aqueous dispersions of solid lipid nanoparticles (SLNs) was designed. Optimal running conditions were evaluated to obtain minimum process time and produce dried SLNs characterized by small size variation. To achieve process optimization, SLN average diameter, SLNs polydispersity index, and drying time were related to three operative variables: process temperature, SLN concentration in the original aqueous dispersions, and nitrogen flow rate as the physical means of the drying process. An experimental design procedure and a multicriteria optimization method, targeting desirability functions, enabled us to obtain the optimal conditions for all responses. Drying time, average diameter, and polydispersity index of dried SLN batches were more favorable than those obtained by freeze-drying identical SLN aqueous dispersions with the same initial nanoparticle concentration.
引用
收藏
页码:299 / 309
页数:11
相关论文
共 17 条
[1]  
Box GEP., 1978, Statistics for experimenters
[2]  
CAPOLONGO A, UNPUB IND P DES DEV
[3]  
CARLSON R, 1992, OPTIMISATION ORGANIC
[4]   Sterilization and freeze-drying of drug-free and drug-loaded solid lipid nanoparticles [J].
Cavalli, R ;
Caputo, O ;
Carlotti, ME ;
Trotta, M ;
Scarnecchia, C ;
Gasco, MR .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1997, 148 (01) :47-54
[5]   Evaporative drying of aqueous dispersions of solid lipid nanoparticles [J].
Cavalli, R ;
Gasco, MR ;
Barresi, AA ;
Rovero, G .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2001, 27 (09) :919-924
[6]  
Deming S.N., 1987, Experimental Design: A Chemometric Approach
[7]   LONG-ACTING INJECTABLE OXYTETRACYCLINE-LIPOSPHERE FORMULATIONS [J].
DOMB, AJ .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 124 (02) :271-278
[8]  
Gasco M.R., 1997, PHARM TECHNOL EUR, V9, P52
[9]  
GASCO MR, 2001, PHARM TECHNOL EUR, V13, P32
[10]  
Khui A., 1987, RESPONSE SURFACES DE